Several reproductive and hormonal factors, like age at menarche, parity, age at menopause, use of oral contraceptives and postmenopausal treatment, have been associated with the risk of renal cell cancer (RCC) in women, but results have not always been consistent. We therefore investigated the association between these factors and the risk of RCC in postmenopausal women participating in the Netherlands Cohort Study on Diet and Cancer.
Information on reproductive history, exogenous hormone use and gynecological surgery was obtained through a self-administered questionnaire at baseline in 1986. After 20.3 years of follow-up, 204 cases and 2280 subcohort members were available for case-cohort analysis. Multivariable hazard ratios (HR) were calculated using Cox Proportional Hazard analysis.
Women who reported a hysterectomy had an increased RCC risk compared to women who did not (HR, 1.42, 95%CI, 1.01-2.00). Women with a natural age at menopause between 45 and 49 years compared to 50-54 years had an increased RCC risk (HR, 1.61; 95%CI, 1.10-2.35). RCC risk was slightly and not statistically significant increased among parous women with three or more children and age at first birth before 25 years compared to nulliparous women (HR, 1.36; 95% confidence interval (CI), 0.84-2.20). No associations were observed with RCC risk for age at menarche, use of oral contraceptives and use of hormonal replacement therapy.
Hysterectomy and age at natural menopause were associated with an increased RCC risk. Other hormonal and reproductive factors and RCC risk were not increased. Further studies are required to establish the mechanism(s) that explain the observed association.
Cancer epidemiology. 2022 May 06 [Epub ahead of print]
Leo J Schouten, Jeroen van de Pol, Milla J Kviatkovsky, Piet A van den Brandt
Department of Epidemiology, School for Oncology and Reproduction (GROW), Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands. Electronic address: ., Department of Epidemiology, School for Oncology and Reproduction (GROW), Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands., Division of Hospital Medicine, University of California San Diego, 200 West Arbor Drive #8485, San Diego, CA 92103, USA., Department of Epidemiology, School for Oncology and Reproduction (GROW), Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands; Department of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre, PO Box 616, 6200 MD Maastricht, The Netherlands.